Company News 

Seven Days: 16 October 2020

Seven Days: 16 October 2020

J&J pauses vaccine trial

Participant falls ill

Johnson & Johnson (US:JNJ) has suspended its clinical trials for a Covid-19 vaccine, after a study participant fell ill. The company said that the person will be reviewed and evaluated by an independent board, as well as internal clinical and safety physicians. It has suspended recruitment to the Phase III trial as a precaution, although noted that with a trial so large it was not unusual for someone to become unwell. Last month UK group AstraZeneca (AZN) paused its trial after one participant developed an unexplained illness.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now